IHS FormWeb
Approved Formulary
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
IHS FormWeb
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Search results for:
buPROPion
buPROPion
Brand names:
Wellbutrin, Wellbutrin SR, Wellbutrin XL
Form
Strength
TABLET, EXTENDED RELEASE, ORAL
100 mg/12 hours; 150 mg/12 hours; 150 mg/24 hours
TABLET, ORAL
75 mg; 100 mg
Display
Antidepressants, Miscellaneous
Class:
28160492
Medication comments:
Enteral Drug Administration notes.
View all
Generic
(Brand)
Comments and Considerations
Recommendations for Administration with Enteral Nutrition
buPROPion
(
Wellbutrin
)
Do NOT crush SR or ER tablets.
If no therapeutic alternative, use immediate-release tablet
Last updated:
Oct. 11, 2020
Black Box Warnings
Suicidal Ideation
Look-Alike/Sound-Alike
buPROPion confused with busPIRone
REMS
Zyban Sustained-Release Tablets
UpToDate
FDA DailyMed Package Insert
MedLinePlus (Patient Information)
MSDS Online
(Brand)
(Wellbutrin)